Jump to content

Reading list

The cartilage reading list

The joint experiment is the starting point. The older metabolic papers explain the ancestry; the human report and a later review change the scale of the question.

Rabbit osteoarthritis

Effect of Intra-articular Injection of AOD9604 with or without Hyaluronic Acid in Rabbit Osteoarthritis Model supplies the cartilage result discussed throughout the site. Its outcome language is the essential starting point for the cartilage essay.

Earlier fat-metabolism experiments

Antilipogenic action of synthetic C-terminal sequence 177-191 of human growth hormone separates fat formation from glycerol release in the rat-tissue assay. Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone develops the fragment's metabolic characterisation.

The more demanding mechanistic test is The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice: the altered receptor system separates acute and chronic responses.

Human tolerability

Safety and Tolerability of the Hexadecapeptide AOD9604 in Humans concerns the oral trial programme in obese adults.

Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance brings a broader safety assessment to the musculoskeletal discussion. That broader caution and the oral exposure report have separate places in the human record.

  1. Effect of Intra-articular Injection of AOD9604 with or without Hyaluronic Acid in Rabbit Osteoarthritis Model ↗
  2. Safety and Tolerability of the Hexadecapeptide AOD9604 in Humans ↗
  3. Antilipogenic action of synthetic C-terminal sequence 177-191 of human growth hormone ↗
  4. The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice ↗
  5. Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone ↗
  6. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance ↗